changzheng30

Sinova (300765.SZ) announced on Tuesday that its subsidiary, Shijiazhuang Pharmaceutical Group Jushi Biopharmaceutical Co. (“Jushi Biologics”), has secured approval from the U.S. Food and Drug Administration (FDA) to launch clinical…

Shanghai, June 12, 2025 — Yema Battery (605378.SH) has announced plans for its Vietnam production base to commence operations in the first quarter of 2026, though the company warned that manufacturing…

Shanghai, June 10, 2025 — A-shares opened June with a robust performance, gaining over 1% in the first five trading days and reigniting investor interest. Data from Wind indicates that 42 brokerages have…

Beijing, June 10, 2025 — China has launched a major policy initiative to transform its livelihood security framework, with the Communist Party Central Committee and State Council jointly issuing Guidelines on Further…

Shanghai, June 15, 2025 — Ping An Bank has ignited a social media firestorm with its new “deposit-to-earn-LABUBU” campaign, offering popular blind boxes from Pop Mart’s iconic IP as a lure…

New York, June 10, 2025 — U.S. markets delivered a mixed performance on Monday, with the S&P 500 and Nasdaq Composite notching fresh late-February highs amid heightened attention on the inaugural…

Multiple brokerages have outlined three key themes for their June strategies: the AI computing power revolution, capacity clearance opportunities, and consumption structure upgrading. CITIC Securities emphasizes the North American AI…

CITIC Securities has released a report stating that risks of upward movement in negotiable certificate of deposit (CD) rates are manageable, with the 1.75% level identified as a favorable entry point…

Chengdu, June 12, 2025 — Industrial Bank’s Chengdu branch has made financial history by launching China’s first “pension bed utilization-linked loan,” a groundbreaking initiative to boost elderly care services and drive…

Beijing, June 6, 2025 — ZhiFei Bio (300122), a leading Chinese biopharmaceutical firm, announced Monday that its subsidiary ZhiFei Lvzhu has received formal acceptance from China’s National Medical Products Administration (NMPA)…